Jeevan Scientific Technology Secures CDSCO Nod for Bed Capacity Expansion.

Jeevan Scientific Technology Ltd has received approval from the Central Drugs Standard Control Organization (CDSCO) to increase the bed capacity at its Bioavailability/Bioequivalence (BA/BE) Study Centre in Hyderabad, strengthening its clinical research infrastructure and expanding its operational capabilities.

The regulatory approval allows the company to increase the facility's capacity from 132 beds and six ICU beds to 156 beds and eight ICU beds at its existing BA/BE Study Centre located at Balanagar, Hyderabad.

The approval follows a successful regulatory inspection conducted by the CDSCO on June 24, 2026, and the company's application seeking enhancement of bed capacity at the facility.

With the expanded capacity, Jeevan Scientific expects to undertake a higher volume of bioavailability and bioequivalence studies, supporting future business growth and improving its ability to serve pharmaceutical clients.

The company said it remains committed to maintaining high standards of quality, regulatory compliance and patient safety across its clinical research operations.